首页> 外文期刊>Journal of Medicine and the Person >Muscular wasting, sarcopenia and cachexia: a trouble for the patients, a challenge for the doctors. The role of the person in this dramatic scenario
【24h】

Muscular wasting, sarcopenia and cachexia: a trouble for the patients, a challenge for the doctors. The role of the person in this dramatic scenario

机译:肌肉萎缩,肌肉减少症和恶病质:给患者带来麻烦,对医生来说是挑战。人在这种戏剧性场景中的角色

获取原文
获取原文并翻译 | 示例
           

摘要

Nowadays, the importance of muscle mass, strength, and metabolic function is demonstrated in both the daily life activities and prognosis. However, the evaluation of muscle mass is not routinely measured by doctors. Clinically, the loss of muscular mass is classified as: muscular wasting, sarcopenia, cachexia. The pathogenesis of sarcopenia-wasting-cachexia is multi-factorial. Indeed, imbalance between anabolic and catabolic signaling, named as “hypermetabolic syndrome”, is the fundamental cause of muscular loss. The evaluation of muscular metabolic impairment should consider several aspects. Body mass index (BMI) is a good first step to use. However, BMI cannot distinguish lean muscular from fatty mass. Therefore, muscle and global catabolic/anabolic metabolism can be measured by: (a) anthropometric measurements, (b) dual-energy X-ray absorptiometry (DEXA or DXA), visceral proteins as blood albumin, transferrin, prealbumin, (c) total lymphocytes blood count, (d) nitrogen balance. Several therapeutic strategies have been proposed to cure muscle loss. Recent works showed that specific mixtures of aminoacids, including essential one, calculated according to stoichiometric ratio, counteract sarcopenia. Other intriguing approaches to muscular loss have been recently proposed. A recent trial showed that Amalirin can reverse muscle wasting in cancer cachexia. In addition, anabolic process can be also modulated by stimulation of selective androgen receptor modulators in humans and by activation of activine type II receptor of Myostatin in both animal models and humans. One other animal study shows that anabolic/catabolic transforming agent MT-102 reverses muscle wasting in rat. Muscular wasting, sarcopenia and cachexia are conditions with important clinical, social and economic impact. However, they are often underestimated by the patients and/or not properly evaluated and cured by physicians. Specific work must be planned and organized to sensitize the “person” on estimating and maintaining the muscle mass and its metabolic and functional roles since they are fundamental in both healthy people and ill patients.
机译:如今,肌肉质量,力量和代谢功能的重要性已在日常生活活动和预后中得到证明。但是,医生通常不会评估肌肉质量。临床上,肌肉质量的损失分类为:肌肉消瘦,肌肉减少症,恶病质。肌肉减少症-浪费-恶病质的发病机制是多因素的。实际上,合成代谢和分解代谢信号之间的不平衡(称为“代谢亢进综合症”)是肌肉损失的根本原因。肌肉代谢障碍的评估应考虑几个方面。体重指数(BMI)是使用的良好第一步。但是,BMI不能区分瘦肌肉和脂肪。因此,可以通过以下方法测量肌肉和整体分解代谢/合成代谢:(a)人体测量,(b)X射线双能吸收法(DEXA或DXA),内脏蛋白质,如血白蛋白,转铁蛋白,前白蛋白,(c)总计淋巴细胞血细胞计数,(d)氮平衡。已经提出了几种治疗肌肉萎缩的治疗策略。最近的研究表明,根据化学计量比计算的特定氨基酸混合物,包括必需氨基酸,可以抵消肌肉减少症。最近提出了其他有趣的肌肉损失方法。最近的一项试验表明,阿马利林可以逆转癌症恶病质中的肌肉消耗。此外,还可以通过刺激人类中选择性雄激素受体调节剂以及在动物模型和人类中激活肌生长抑制素的II型激活素受体来调节合成代谢过程。另一项动物研究表明,合成代谢/分解代谢转化剂MT-102可逆转大鼠的肌肉消耗。肌肉萎缩,肌肉减少症和恶病质是具有重要临床,社会和经济影响的疾病。但是,它们通常被患者低估和/或未被医生正确评估和治愈。必须计划和组织具体的工作,以使“人”对估计和维持肌肉质量及其代谢和功能作用敏感,因为它们对于健康人和患病患者都是至关重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号